• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

HIMSS26: Verily and Samsung Partner to Integrate Galaxy Watch 8 into Precision Health Platform

by Fred Pennic 03/09/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
HIMSS26: Verily and Samsung Partner to Integrate Galaxy Watch 8 into Precision Health Platform

What You Should Know

  • The Partnership: Verily Life Sciences and Samsung Electronics America are collaborating to integrate the Samsung Galaxy Watch 8 directly into Verily’s precision health platform, Pre.
  • The Clinical Goal: The joint solution is designed to accelerate research for life sciences and government customers by allowing them to run real-world studies using continuous, consumer-grade wearable data.
  • The Hardware: The Galaxy Watch 8 acts as a robust clinical tool, bringing FDA-cleared features like moderate-to-severe obstructive sleep apnea assessment and irregular heart rhythm (AFib) notifications, alongside continuous SpO2 and body composition tracking.
  • The Software Ecosystem: Verily will ingest this sensor data into its Viewpoint Evidence solution. Sponsors will utilize Verily’s Refinery tool to harmonize the data and its Workbench tool for AI/ML-driven analysis and modeling.
  • The Sponsor Value: Research sponsors gain exclusive access to a longitudinal dataset of consented participants. This harmonizes Samsung sensor data with medical records, surveys, and third-party data at the individual level, solving one of the biggest data-silo issues in modern clinical trials.

Bridging Consumer Hardware and Clinical Software

Historically, the barrier to using consumer wearables in clinical trials hasn’t been the hardware; it has been the fragmented, messy backend data. Samsung has already done the heavy lifting on the hardware and regulatory front. The Galaxy Watch 8 features FDA clearance for moderate-to-severe obstructive sleep apnea assessments and irregular heart rhythm notifications, providing clinical-grade guardrails for its biometric sensors.

Verily’s role is to make that data actually usable for life science companies. Through this partnership, Samsung’s sensor data will pipe directly into Verily’s Viewpoint Evidence solution. From there, research sponsors can use Verily’s AI/ML tools—specifically Refinery for data harmonization and Workbench for modeling—to make sense of the billions of data points being generated.

“The use of consumer-friendly devices in clinical research makes it easier for participants to engage in studies, while enabling sponsors to use advanced biomarkers to generate high quality data,” noted Scott Burke, Chief Technology Officer at Verily.

The Longitudinal Data Advantage

For pharmaceutical companies and government researchers, the true value of this partnership is the holistic patient view. Sponsors utilizing Verily’s platform gain access to a rich dataset of consented participants where continuous Samsung sensor data is harmonized directly with the patient’s Electronic Health Records (EHR), survey responses, and other third-party data.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Trials

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |